ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
PMC/PubMed Indexed Articles
A 2-year Double-Blind RCT Follow-up Study with Fermented Papaya Preparation (FPP) Modulating Key Markers in Middle-Age Subjects with Clustered Neurodegenerative Disease-Risk Factors
Direct Measurement of Lipase Inhibition by Orlistat Using a Dissolution Linked In Vitro Assay

View More »

Publication Policies and Ethics
Google Scholar citation report
Citations : 1089

Clinical Pharmacology & Biopharmaceutics received 1089 citations as per Google Scholar report

Flyer image
Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Publon image
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
View More
Useful Links
Recommended Journals
View More
Related Subjects
View More
Share This Page

Biomarker Discovery

Biomarker discovery involves identifying biological markers—molecules found in blood, other body fluids, or tissues—that indicate the presence or progression of a disease, or the effects of a treatment. These biomarkers can help in diagnosing diseases, predicting outcomes, and monitoring therapeutic responses.
Biomarker discovery is crucial for advancing precision medicine by providing insights into disease mechanisms and treatment effects. It involves techniques such as genomics, proteomics, and metabolomics to find novel biomarkers that can be used for early diagnosis, personalized treatment plans, and monitoring disease progression.

Biomarker Discovery

Expert PPTs

Speaker PPTs

Conference Proceedings